- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT03517527
The Effect of The Walking Exercise Training Given According to Transtheoretical Model, and Follow-Up on Improving Exercise Behavior and Metabolic Control in Type 2 Diabetic Patients
OBJECTIVE This study aims to find out the effects of walking exercise training, which is given according to Transtheoretical Model (TTM), and follow-up on improving exercise behavior and metabolic control in type 2 diabetic patients.
RESEARCH DESIGN AND METHODS The study was conducted as a pre-test, post-test experimental model with 76 intervention (INT) groups and 76 control (CON) groups adult type 2 diabetic patients providing the criteria of the study and followed-up by the diabetes polyclinic of Adıyaman Education and Research Hospital. Patient introduction form (PIF), TTM scales and pedometer were used to collect the data. TTM based training was given to the intervention group according to the patients' change stages at hospital 10 weeks once per every 2 weeks. PIF, TTM scales were applied after the training. PIF, TTM scales were applied to the groups 9 months after the pre-test again.
Tutkimuksen yleiskatsaus
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Patients who were diagnosed with type-2 diabetes at least six months before, received basic diabetes information, received insulin and/or oral antidiabetic treatment, whose arterial blood pressure was in systolic ≤ 160 mmHg and diastolic ≤ 100 mmHg, who had HbA1c 7% and over, who were literate and had no communication problems were included in the study.
Exclusion Criteria:
- Those who had developed diabetes-related complications (advanced), were pregnant, diagnosed with cancer, had physical and mental problems that prevent walking were excluded from the study.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Nelinkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Kokeellinen: Interventio
|
Muut nimet:
|
Ei väliintuloa: Ohjaus
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Patient Presentation Form
Aikaikkuna: baseline collected
|
The patient presentation form includes questions that question the sociodemographic characteristics and habits of patients, their knowledge of diabetes and its treatment, their exercise status
|
baseline collected
|
questions that evaluate the metabolic control variables.
Aikaikkuna: Change from Baseline at 9 months
|
FBS, SBS, total cholesterol, HbA1c, LDL, triglyceride, diastolic and systolic BP
|
Change from Baseline at 9 months
|
Stages of Change for Exercise Questionnaire
Aikaikkuna: Change from Baseline at 9 months
|
It was developed by Prochaska and DiClemente, adapted by Marcus et al. to exercise.
It was adapted to Turkish society by Ay and Temel in 2007.
The scale consists of five questions and reveals the stage of change where the individual in (pre-thinking, thinking, preparation, taking action and maintenance).
|
Change from Baseline at 9 months
|
Exercise Processes of Change Scale
Aikaikkuna: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
Exercise Processes of Change Scale is based on a 5-point Likert type and consists of 28 items.
The maximum score that an individual can get on the scale is 140, the minimum score is 28.
The scale consists of 10 sub-dimensions and 2 main processes (behavioral process and cognitive process) facilitating change involving these sub-dimensions.
Cognitive processes are increased awareness, dramatic help, environmental reassessment, self-reassessment, social independence.
Behavioral processes are opposition, helping relationships, empowerment management, self-emancipation and stimulus control.
The higher scale scores indicate the higher chance of success of the change.
|
Change from Baseline at 9 months
|
Exercise Self-Efficacy Scale
Aikaikkuna: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
The scale consists of six items, in the form of five-point Likert.
The maximum score that can be taken from the scale is 30 and the minimum score is 6.
In the general evaluation of the scale, according to the general average composed of item score averages, the self-efficacy of high-value-average subjects is high, and the self-efficacy of subjects below the average is considered to be low.
|
Change from Baseline at 9 months
|
Exercise Decisional Balance Scale
Aikaikkuna: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
There are two sub-dimensions that assess subjective perception including perceived benefits of exercise practice and perceived harmfulness of exercise.
The scale is based on 5 point Likert type and consists of 10 items.
The overall score of the scale is formed by subtracting the total score of the perceived harmfulness from the total score of the perceived benefit of the exercise practice.
The maximum score can be taken from the scale is 20 and the minimum score is -20.
The negative result indicates that in the exercise decisional balance, the perceived harmfulness is dominant and the positive result indicates that the perceived benefit of exercise practice is dominant on the scale.
|
Change from Baseline at 9 months
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- MunzurU
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Tyypin 2 diabetes mellitus
-
Griffin HospitalCalifornia Walnut CommissionValmisTYYPIN DIABETES MELLITUS 2Yhdysvallat
-
Diabetes Free, Inc.Ei vielä rekrytointiaDiabetes mellitus tyyppi 2 - Insuliinilla hoidettu
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Ei vielä rekrytointiaTyypin 2 diabetes mellitus
-
Endogenex, Inc.Ei vielä rekrytointiaDiabetes mellitus, tyyppi 2 | Diabetes | Tyypin 2 diabetes mellitus | Tyypin 2 diabetes | Tyypin 2 diabetes
-
Nanjing First Hospital, Nanjing Medical UniversityRekrytointiTyypin 2 diabetes mellitusKiina
-
Xiangya Hospital of Central South UniversityRekrytointi
-
University of Alabama at BirminghamValmisTyypin 2 diabetes mellitusYhdysvallat
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...ValmisTyypin 2 diabetes mellitusYhdistynyt kuningaskunta
-
Universiti Sains MalaysiaValmis
-
University of Alabama at BirminghamUnited States Department of Defense; Loma Linda University; Brenda Davis Nutrition... ja muut yhteistyökumppanitValmisTyypin 2 diabetes mellitus